Table 6 Prevalence of hyperkalaemia among subjects taking 1–4 drugs increasing serum potassium level (angiotensin-converting enzyme inhibitors + angiotensin II receptor blockers + aldosterone antagonists + potassium-sparing diuretics + potassium-containing agents)
No. of drugs | CC | sMDRD | ||
|---|---|---|---|---|
< 60 ml/min | ≥ 60 ml/min | < 60 ml/min/1.73m2 | ≥ 60 ml/min/1.73m2 | |
1; n (%) of subjects with hyperkalaemia | 102/669 (15.26)* & | 73/952 (7.67) & | 73/391 (18.67)# & | 102/1230 (8.29) |
2; n (%) of subjects with hyperkalaemia | 57/258 (22.09)* | 22/248 (8.87) | 52/180 (28.89)# | 27/326 (8.28) |
3; n (%) of subjects with hyperkalaemia | 14/54 (25.93) | 13/51 (25.49) | 14/30 (46.67)# | 13/75 (17.33) |
4; n (%) of subjects with hyperkalaemia | 1/1 (100) | 0/33 (0) | 1/1 (100) | 0/3 (0) |